Evidence map›Paper›PMID 38139160›Full record

ArticleInternational journal of molecular sciences2023

Unsymmetrical Pd(II) Pincer Complexes with Benzothiazole and Thiocarbamate Flanking Units: Expedient Solvent-Free Synthesis and Anticancer Potential.

Vladimir A Kozlov, Diana V Aleksanyan, Svetlana G Churusova, Aleksandr A Spiridonov, Ekaterina Yu Rybalkina, Evgenii I Gutsul, Svetlana A Aksenova, Alexander A Korlyukov, Alexander S Peregudov, Zinaida S Klemenkova

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Vladimir A KozlovA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Diana V AleksanyanA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Svetlana G ChurusovaA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Aleksandr A SpiridonovA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Ekaterina Yu RybalkinaN. N. Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation, Kashirskoe shosse 23, 115478 Moscow, Russia.
Evgenii I GutsulA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.ORCID 0000-0002-2835-4674
Svetlana A AksenovaA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.ORCID 0000-0003-2821-6252
Alexander A KorlyukovA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Alexander S PeregudovA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
Zinaida S KlemenkovaA. N. Nesmeyanov Institute of Organoelement Compounds, Russian Academy of Sciences, ul. Vavilova 28, Str. 1, 119334 Moscow, Russia.
A. N. Nesmeyanov Institute of Organoelement Compounds · RUMinistry of Health of the Russian Federation · RUPlekhanov Russian University of Economics · RU

Funding

Russian Science Foundation 22-13-00267
6 · The paper itself

Abstract

Driven by the growing threat of cancer, many research efforts are directed at developing new chemotherapeutic agents, where the central role is played by transition metal complexes. The proper ligand design serves as a key factor to unlock the anticancer potential of a particular metal center. Following a recent trend, we have prepared unsymmetrical pincer ligands that combine benzothiazole and thiocarbamate donor groups. These compounds are shown to readily undergo direct cyclopalladation, affording the target

Indexed as

Coordination ComplexesNeoplasmsBenzothiazolesHumansMagnetic Resonance SpectroscopySolventsBenzothiazolesCoordination ComplexesSolventsbenzothiazolescytotoxicitypalladiumpincer complexessolid-phase synthesisthiocarbamates

Identifiers

PMID38139160
PMCPMC10744248
OpenAlexW4389566048

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.